Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 61-72 of 137
» View wsbtradio.com items only
    May 11, 2012 | Allentown Morning Call
  1. Claim: PA taxpayers footed $234K bill for "corporate front group" that pushes legislation.

    Capitol Ideas with John L. Micek
    Liberal advocacy groups are stepping up their attacks on the American Legislative Exchange Council (ALEC), charging this week that the think-tank has been the recipient of tens of thousands of dollars in Pennsylvania taxpayers' money. Citing documents...
  2. Apr 30, 2012 |Story| South Florida Sun-Sentinel
  3. Nuevo rival para el Viagra

    Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer Inc.
    Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer...

    Tags: Cialis (drug), Vivus Inc., Drugs and Medicines, Pfizer Inc., Viagra (drug)

  4. Apr 30, 2012 |Story| Baltimore Sun
  5. FDA approves new drug for erectile dysfunction

    Men now have a new option to treat erectile dysfunction. The U.S. Food and Drug Administration has approved the new drug Stendra to treat the illness that causes problems in the sex lives of 30 million men. It is the first erectile dysfunction drug in a...

    Tags: Jack Nicholson, Chemical Industry, Viagra (drug), Health, Physical Conditions

  6. Apr 21, 2012 |Story| Baltimore Sun
  7. Consolidation wave poised to hit state's health care services, biopharma sectors

    Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals. Both homegrown companies — Human Genome Sciences Inc. and Catalyst...

    Tags: HealthSpring Inc., AstraZeneca Plc, MedImmune Inc., Benlysta (drug), Economy, Business and Finance

  8. Jan 9, 2012 |Story| Los Angeles Times
  9. |Story
  10. Apr 19, 2012 |Story| Baltimore Sun
  11. Human Genome Sciences rebuffs $2.6 billion offer from GlaxoSmithKline

    Shares of Human Genome Sciences doubled in Thursday morning trading on news that a major British biopharmaceutical company offered to buy it for $2.6 billion, which the Rockville company rejected as too low. Human Genome, which uses the human DNA...

    Tags: Cancer, Chemical Industry, Heart Disease, Benlysta (drug), Economy, Business and Finance

  12. Dec 12, 2011 | Los Angeles Times
  13. SEC accuses Stiefel Laboratories of defrauding employee shareholders

    Money & Company
    The Securities and Exchange Commission has accused Stiefel Laboratories, a subsidiary of GlaxoSmithKline, and the subsidiary’s former chief executive of defrauding employees and other shareholders by buying back the company’s private stock...
  14. Mar 6, 2012 | Allentown Morning Call
  15. Health care non-profits invited to bid for bucks

    Health
    Does your health care non-profit have an impact on the community? GlaxoSmithKline wants to know. The pharmaceutical company is holding its 16th annual IMPACT awards to recognize community-based nonprofits that provide access to healthcare for the...
  16. Mar 19, 2012 | Los Angeles Times
  17. The Morning Fix: '21 Jump Street' cleans up! O'Donnell hits road.

    Company Town
    21 Jump Street finishes on top of the box office. James Murdoch exits another board. Rosie O'Donnell hits the road....
  18. Sep 27, 2011 |Story| Chicago Tribune
  19. Drug companies pay $25 million to Illinois doctors

    At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms.
    At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms. Doctors in the...

    Tags: Chicago, AstraZeneca Plc, Merck & Company Incorporated, Finance, Economy, Business and Finance

  20. Jun 20, 2011 |Story| Reuters
  21. |Story
  22. Jun 16, 2011 |Story| Coastline Pilot
  23. Mailbag: Should they sell seashells at store?

    Perhaps instead of fighting over how many merchants in town sell seashells, they should consider not selling them at all ("Fighting over some seashells," Dave Hansen column, June 2). Yes, I know, they are big sellers, and make money for the merchants....

    Tags: Diseases and Illnesses, Autism, Corporate Crime, Fraud, Laguna Beach

< Previous1 2 3 4 5  6  7 8 9 10 11-12Next >
Original site for GlaxoSmithKline PLC topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
GlaxoSmithKline PLC Photos
Dr. Jeffrey Bloss has joined Astellas US LLC as vice pr...
(November 28, 2012)
Dr. Jeffrey Bloss, vice president of scientific and medical affairs, Astellas US LLC
Third grader Kira Lingle of Quakertown rolls up a strea...
(July 10, 2012)
Science in the Summer program
A bottle of Xenical, a weight-loss aid made by GlaxoSmi...
(May 9, 2012)
GlaxoSmithKline launches hostile tender offer for Human Genome Sciences